Khalid Ahmed: The HALO Study to Understand Quality of Life After Childhood Hematological Disorders
Khalid Ahmed, Haematology Registrar at Sheffield Teaching Hospitals NHS Foundation Trust, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I am delighted to share with you the first publication (protocol paper) in this vital research project. While survival rates for children with severe blood disorders like Sickle cell disease, transfusion dependent beta thalassaemia, and acute leukaemia have dramatically improved, we still know far too little about their quality of life after survival. What are their long term physical, mental and social outcomes? How surviving childhood condition impacts education, employment and family life?
The HALO study (Health outcomes in adults survivors of severe haematological disorders in childhood) led by reseachers across Northern England is designed to find out. This is not just a study; it is the most extensive data linkage and patient reported outcome analysis of these diseases in the UK.
This project is vital because:
- It centres the patient voice by directly asking survivors using validated surveys.
- It connects the dots by securely linking national data on hospital use,mental health, and reproductive outcomes.
- It addresses health inequality since SCD and TDT affects primarily people of ethnic minorities.
- The insights will guide the NHS in designing better support services, counseling programs, and follow up care for thousands of adults living with the long term effects of these conditions.”
Title: Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study
Authors: Khalid Ahmed, Ivana Holloway, Kate Absolom, Samantha J Mason, Ruben Mujica-Mota, Georgios Gkountouras, Adam Martin, Thuvia Flannery, Michael Richards, Emma Astwood, Sam Ackroyd, Brigit Greystoke, Diana M Greenfield, Quentin Hill, Beki James, Michelle Kwok- Williams, Robert D Murray, Clare Samuelson, David Simcox, John A Snowden, Joseph Sharif, Nandini Sadasivam, Richard Feltbower, Adam Glaser
Read the Full Article on BMJ Open
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy